MARKET

VNRX

VNRX

VOLITIONRX
AMEX

Real-time Quotes | Nasdaq Last Sale

3.410
+0.130
+3.96%
Opening 11:06 08/12 EDT
OPEN
3.410
PREV CLOSE
3.280
HIGH
3.453
LOW
3.350
VOLUME
62.99K
TURNOVER
--
52 WEEK HIGH
6.84
52 WEEK LOW
2.220
MARKET CAP
155.40M
P/E (TTM)
-7.7447
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average VNRX stock price target is 7.75 with a high estimate of 10.00 and a low estimate of 6.00.

EPS

VNRX News

More
VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Friday, August 14, at 8:30 a.m. Eastern time to discuss its financial and operating results for the second quarter 2020, in addition to providing a business
PR Newswire · 2d ago
Stocks To Watch: Big Focus On Big Tech
Seeking Alpha · 07/25 12:26
Seeking Alpha Catalyst Watch
Seeking Alpha · 07/24 19:06
ZYXI, IMV among premarket losers
Seeking Alpha - Article · 07/15 12:12
55 Biggest Movers From Yesterday
Gainers Perceptron, Inc. (NASDAQ: PRCP) shares jumped 107% to close at $6.50 on Tuesday after the company received an order from an automotive supplier for its in-line measurement technology.
Benzinga · 07/15 08:49
TSLA, HBI among premarket gainers
Seeking Alpha - Article · 07/14 12:22
The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13)
Benzinga · 07/14 12:04
VolitionRx up big on encouraging COVID-19 test data
Seeking Alpha - Article · 07/14 10:46

Industry

Medical Equipment, Supplies & Distribution
+1.47%
Healthcare Equipment & Supplies
+1.56%

Hot Stocks

Symbol
Price
%Change

About VNRX

VolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The Company's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The Company is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The Company's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. It has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.
More

Webull offers kinds of VolitionRX Ltd stock information, including AMEX:VNRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VNRX stock methods without spending real money on the virtual paper trading platform.